Company Snapshot


Change Company Name
 
Shukra Pharmaceuticals Ltd
Pharmaceuticals - Indian - Formulations
BSE Code
524632
NSE Symbol
N.A
P/E
59.94
ISIN Demat
INE551C01044
Div & Yield %
0.03
EPS
0.5
Book Value
2.05
Market Cap (Rs Cr.)
1,312.32
Face Value
1
Stock Price Details
Last Price (₹) 30.19
Change +0.81 (2.78%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 29.50 - 30.75
52-Week Range 12.97 - 65.26
Beta (1 Year) 0.69
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
 
Corporate Announcements
Shukra Pharmaceuticals to conduct EGM
Shukra Pharmaceuticals to convene board meeting
Board of Shukra Pharmaceuticals recommends final dividend
Shukra Pharmaceuticals reports consolidated net loss of Rs 1.72 crore in the March 2026 quarter
Shukra Pharmaceuticals to discuss results
Shukra Pharmaceuticals fixes board meeting date
Shukra Pharmaceuticals standalone net profit rises 544.30% in the December 2025 quarter
Shukra Pharmaceuticals to hold board meeting
Shukra Pharmaceuticals revises board meeting date
Shukra Pharma inks MoU with US-based Borns Medical Robotics for surgical robotic systems
Corporate Details
Incorporation Year : 1993
Chairman : Dakshesh Shah
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Formulations
Registered Office :

Shukra Pharmaceuticals Ltd
3 rd Floor Dev House,
Opp WIAA Office Judges Bungalo,
Ahmedabad,
Gujarat - 380054,
Phone : 91-079-66522247/27498515,
Fax : N.A.
E-Mail : info@shukrapharmaceuticals.com
URL : http://www.shukrapharmaceuticals.com
Investor Returns
Period Date Price(₹) Returns (%)
1Week 05-Jun-2026 31.46 -4.74
1Month 12-May-2026 30.28 -1.02
3Month 12-Mar-2026 40.09 -25.24
6Month 12-Dec-2025 51.16 -41.42
1Year 12-Jun-2025 14.91 +101.01
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
No Data Found
Peer Groups : Pharmaceuticals - Indian - Formulations
Company Last Price(₹) Change(%) 52Week High(₹) 52Week Low(₹) Market Cap(₹)
Torrent Pharmaceuticals Ltd 4,574.95 +0.11 4,714.50 3,139.50 154,837.10
Ajanta Pharma Ltd 3,129.35 -0.34 3,314.80 2,335.00 39,096.73
Gland Pharma Ltd 2,261.10 -1.93 2,395.00 1,575.00 37,299.03
Rubicon Research Ltd 1,294.35 +0.52 1,371.75 571.00 21,324.46
ERIS Lifesciences Ltd 1,402.90 +2.64 1,909.55 1,237.90 19,439.60

Mail Us

Exclusive E-mail Id for redressal of investor grievances

jyotiinvestorgrievance@rediffmail.com
ATTENTION INVESTORS:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.      |      " KYC is one time excercise while dealing in securities markets-once KYC is done through a SEBI registered intermediary (broker,DP,Mutual Fund etc),you need not undergo the same process again when you approach another intermediary."      |      "Contents which are exclusively for Non-Broking Products/Services, Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."      |      “The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us. ”      |      "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." .......... Issued in the interest of investors"
logo
Address

B- 78, 3rd Floor, Defence Colony
New Delhi – 110 024

RISK DISCLOSURES ON DERIVATIVES

Attention Investors

  • Stock Brokers can accept securities as margin only by pledge.
  • Update your mobile number & email Id with your Stock Broker/Depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month

Precautions for clients dealing in Options

  • Do not Share your trading credentials – login id & passwords including OTP’s.
  • Do not Trade in leveraged products like options without proper understanding, which could lead to losses.
  • Do not Write/ sell options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Do not Deals in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  • Do not Trade in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.

NSE SEBI CM INZ000017939 | NSE SEBI F&O INZ000017939 | BSE SEBI CM INZ000017939 | NSDL : IN-DP-443-2019 | CDSL: IN-DP-443-2019 | NCDEX SEBI INZ000017939 | MCX SEBI INZ000017939

@2023 Jyoti Broking Pvt. Ltd. All rights reserved

Designed, developed and powered by CMOTS Infotech (ISO 9001:2015 certified)